2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
2
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Thrombocythemia, Essential
1
Recurrence
1
Primary Myelofibrosis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Interventions
pembrolizumab
437
Carboplatin
322
Nivolumab
291
Cyclophosphamide
281
Specimen Handling
271
Magnetic Resonance Spectroscopy
257
Cisplatin
254
Paclitaxel
247
Radiotherapy
230
Gemcitabine
183
Dexamethasone
182
Biopsy
182
durvalumab
168
atezolizumab
150
Rituximab
138
Doxorubicin
135
Lenalidomide
134
Bevacizumab
132
Ipilimumab
130
Docetaxel
129
Capecitabine
120
Radiation
119
Radiosurgery
113
Oxaliplatin
113
Pemetrexed
112
Etoposide
111
Fluorouracil
109
venetoclax
107
fludarabine
106
Prednisone
97
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
INCB057643
×
Clear all
NCT04279847
2026-04-01
LIMBER
Incyte Corporation
Phase 1
Active not recruiting
140 enrolled